on SENSORION (EPA:ALSEN)
Sensorion Announces Participation in Investor Conferences
Biotechnology company Sensorion, which specializes in hearing therapies, has announced its participation in several investor conferences in September and October 2025. In New York, the 27th Annual HC Wainwright Global Investment Conference and the Baird 2025 Global Healthcare Conference will be held from September 8 to 10 and September 9 and 10, respectively. In Paris, the European Midcap Event will take place on September 30 and October 1. The Portzamparc Biotech & Health Seminar will be held there on October 1 and 2. Finally, the 9th Annual Genetic Medicines Conference will take place in New York on October 21.
R. P.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all SENSORION news